LISA CHILDRESS: Open Payments
NPI 1770983785 · NEW BOSTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 8 payments from 4 companies in 2025. Trend: 2023 $150 · 2024 $456 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $149 |
| Supernus Pharmaceuticals, Inc. | 1 | $101 |
| Vanda Pharmaceuticals Inc. | 1 | $70 |
| ABBVIE INC. | 3 | $52 |
Products named: CAPLYTA, Qelbree, FANAPT, VRAYLAR.
Industry payments across OH — which companies pay providers there.
